Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study.
Russo A, Pisaturo M, Monari C, Ciminelli F, Maggi P, Allegorico E, Gentile I, Sangiovanni V, Esposito V, Gentile V, Calabria G, Pisapia R, Carriero C, Masullo A, Manzillo E, Russo G, Parrella R, Dell'Aquila G, Gambardella M, Ponticiello A, Onorato L, Coppola N; CoviCamp Group. Russo A, et al. Among authors: sangiovanni v. Pathogens. 2023 Jul 25;12(8):973. doi: 10.3390/pathogens12080973. Pathogens. 2023. PMID: 37623933 Free PMC article.
ITPase activity modulates the severity of anaemia in HCV-related cirrhosis treated with ribavirin-containing interferon-free regimens.
Coppola N, De Pascalis S, Messina V, Di Caprio G, Martini S, de Stefano G, Starace M, Stornaiuolo G, Stanzione M, Ascione T, Minichini C, Sangiovanni V, Zampino R, Calò F, Rinaldi L, Persico M, Federico A, Buonomo AR, Borgia G, Gaeta GB, Filippini P, Gentile I. Coppola N, et al. Among authors: sangiovanni v. Antivir Ther. 2017;22(7):551-558. doi: 10.3851/IMP3134. Epub 2017 Feb 6. Antivir Ther. 2017. PMID: 28165327
Interferon-Free Regimens in Hepatitis B Surface Antigen/Anti-Hepatitis C Virus Positive Patients: The Need to Control Hepatitis B Virus Replication to Avoid Hepatitis B Virus Reactivation.
Macera M, Stanzione M, Messina V, D'Adamo G, Sangiovanni V, Mioglioresi L, Fontanella L, De Pascalis S, Stornaiuolo G, Galeota Lanza A, Ascione T, Sagnelli E, Gentile I, Piai G, Gaeta GB, Coppola N. Macera M, et al. Among authors: sangiovanni v. Clin Gastroenterol Hepatol. 2017 Nov;15(11):1800-1802. doi: 10.1016/j.cgh.2017.05.032. Epub 2017 May 26. Clin Gastroenterol Hepatol. 2017. PMID: 28552801 No abstract available.
Virological patterns of HCV patients with failure to interferon-free regimens.
Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Adinolfi LE, Claar E, Precone D, Stornaiuolo G, Stanzione M, Ascione T, Caroprese M, Zampino R, Parrilli G, Gentile I, Brancaccio G, Iovinella V, Martini S, Masarone M, Fontanella L, Masiello A, Sagnelli E, Punzi R, Salomone Megna A, Santoro R, Gaeta GB, Coppola N. Starace M, et al. Among authors: sangiovanni v. J Med Virol. 2018 May;90(5):942-950. doi: 10.1002/jmv.25022. Epub 2018 Feb 1. J Med Virol. 2018. PMID: 29315640
Patients with HCV genotype-1 who have failed a direct-acting antiviral regimen: virological characteristics and efficacy of retreatment.
Pisaturo M, Starace M, Minichini C, De Pascalis S, Macera M, Occhiello L, Messina V, Sangiovanni V, Claar E, Precone D, Stornaiuolo G, Stanzione M, Gentile I, Brancaccio G, Martini S, Masiello A, Megna AS, Coppola C, Federico A, Sagnelli E, Persico M, Lanza AG, Marrone A, Gaeta GB, Coppola N. Pisaturo M, et al. Among authors: sangiovanni v. Antivir Ther. 2019;24(7):485-493. doi: 10.3851/IMP3296. Antivir Ther. 2019. PMID: 30758299
DAA-based treatment for HIV-HCV-coinfected patients: analysis of factors of sustained virological response in a real-life study.
Alessio L, Onorato L, Sangiovanni V, Borrelli F, Manzillo E, Esposito V, Simeone F, Martini S, Capoluongo N, Leone S, Di Filippo G, D'Abbraccio M, Aprea L, Megna AS, Milano E, Rizzo V, Saracino A, Coppola N. Alessio L, et al. Among authors: sangiovanni v. Antivir Ther. 2020;25(4):193-201. doi: 10.3851/IMP3353. Antivir Ther. 2020. PMID: 32314978
72 results